Fizyhealth
RxFul for cash-pay

RxFul for cash-pay clinics: how the economics work

RxFul is white-label pharmacy infrastructure for cash-pay clinics and telehealth brands. The economics combine published tiered SaaS — from $0 GLP through $1,997 per month — with per-order fulfillment fees on top of drug cost. For cash-pay clinics, margin depends on whether platform tiers plus fulfillment beat pass-through per-vial pricing you can see before you quote the patient.

If you run a cash-pay or concierge clinic and need to understand RxFul's all-in cost structure, this page explains the economics and how a pass-through model like Fizy Health makes margin visible up front.

Compare Fizy Health vs RxFul

Proudly Partnered With

What does RxFul mean for cash-pay economics?

For a cash-pay clinic, RxFul determines two cost layers: monthly platform SaaS and per-order drug plus fulfillment fees. RxFul publishes SaaS tiers on rxful.com — Rx-GLP at $0 for GLP-only access, Rx-Bronze at $997 for the full SKU catalog, Rx-Silver at $1,497 with full white-label customization and volume-based fulfillment pricing, and Rx-Gold at $1,997 with API access and dedicated onboarding. Per-vial drug rates and fulfillment fees are not listed publicly. In a cash-pay model where revenue is the spread between landed cost and patient price, the owner's risk is quoting patients before confirming all-in cost across platform tier, drug, and logistics.

Who feels the economics

Cash-pay margin is set by what each role can see.

In a cash-pay clinic, pricing visibility flows through three roles, each of whom needs different numbers to do their job.

  • Owners

    Founders setting patient prices.

    Owners set program prices off landed cost, so they need platform SaaS, per-vial drug cost, and fulfillment fees to be predictable. With RxFul, the monthly tier is published but per-vial rates require onboarding — the owner's risk is building patient pricing before confirming drug and fulfillment on top of SaaS.

  • Operators

    Ops leads protecting the spread.

    Operations staff watch the spread on every order — cold-chain handling, volume-based fulfillment on Silver, and any fees that erode margin. They need all-in landed cost surfaced clearly so a refill batch does not quietly cost more than the patient price assumed.

  • Prescribers

    Providers quoting at the visit.

    Prescribers and front-desk staff often quote patients during the visit. When per-vial cost is only available after tier selection and onboarding, visit-time quoting relies on estimates rather than live landed cost on each SKU.

What drives cash-pay landed cost on RxFul

Landed cost in a cash-pay clinic is per-vial drug cost plus platform SaaS amortized across volume plus fulfillment fees. RxFul's published tiers make the platform layer visible — you know full catalog access costs $997 per month before you sign — but drug and fulfillment economics still arrive during onboarding. Silver adds volume-based fulfillment pricing; Gold adds priority allocation and custom packaging runs that affect per-order economics.

For cash-pay GLP-1, hormone, and peptide programs, compare your top five SKUs on all-in landed cost before checkout — including monthly SaaS divided across expected order volume. A $997/mo Bronze tier that unlocks the catalog still adds roughly $12 per order at 80 refills per month before drug cost. Predictability matters as much as the headline tier price.

How pass-through pricing changes cash-pay margin

Fizy Health takes a pass-through approach built for cash-pay margin. It shows resolved 503A per-vial cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment — $0/mo plus pass-through pricing and 9% facilitation. The owner sets patient prices on the same number the clinic will actually pay, and the prescriber can quote at the visit on live cost.

On the operations side, one clinic cart batches refill day and cart validation catches invalid SIGs, prescriber state mismatches, and stock gaps before payment, so the clinic stops paying for orders that get rejected after checkout. For a cash-pay clinic ordering GLP-1, hormone, or peptide refills at volume, the combined effect is margin you can see before you order and fewer surprises that erode the spread.

Which pricing model fits a cash-pay clinic?

RxFul fits if

RxFul

Patient-brand infrastructure is the primary requirement.

  • You are launching clinic-branded patient checkout and accept tiered SaaS plus fulfillment fees as your cost model.
  • You need 503B office-use bulk alongside patient-specific 503A mail-order and white-label portal infrastructure is the priority.
  • Per-vial margin visibility before consult matters less than patient-brand infrastructure and published SaaS tiers.
Consider Fizy Health if

Fizy Health

You want landed cost before the consult — and validation before you pay.

  • You set patient prices off landed cost and need per-vial 503A cost visible before checkout.
  • You order GLP-1, hormone, or peptide refills at volume and want one cart with validation before payment.
  • You want the facilitation fee disclosed at checkout with no $997/mo catalog gate to see your formulary.
If you choose Fizy Health

What a cash-pay clinic gets from pass-through pricing.

RxFul and Fizy Health both connect cash-pay clinics to 503A partners. These outcomes protect margin when pricing is visible and orders are validated before you pay.

See all features
Keep evaluating RxFul

More answers in the RxFul evaluation guide.

See the full RxFul guide
FAQ

What cash-pay clinics ask about RxFul.

  • Definition

    What is RxFul for cash-pay clinics?

    For cash-pay clinics, RxFul is white-label pharmacy infrastructure with tiered SaaS plus fulfillment fees. It provides patient-facing checkout under the clinic brand and routes orders to licensed 503A partners.

  • Pricing

    How does RxFul pricing affect cash-pay margin?

    Cash-pay margin is the spread between landed cost and patient price. RxFul combines published SaaS tiers ($0–$1,997/mo) with per-vial drug and fulfillment fees that require onboarding — so all-in cost is not fully visible from the public site alone.

  • Fees

    What should cash-pay clinics ask about RxFul fees?

    Ask for per-vial rates on your top SKUs, fulfillment fees including cold-chain and volume-based pricing on Silver, and whether SaaS tier cost holds as volume scales. The all-in landed cost — not the tier headline — sets your real margin.

  • Tiers

    Which RxFul tier do cash-pay clinics need?

    Rx-GLP ($0/mo) covers GLP products only. Cash-pay clinics prescribing hormones, peptides, or a broad formulary need Rx-Bronze ($997/mo) or higher for full SKU catalog access. White-label customization requires Rx-Silver ($1,497/mo) or above.

  • Visibility

    Can I quote a patient at the visit with RxFul?

    Because per-vial drug rates require onboarding beyond published SaaS tiers, visit-time quoting may rely on estimates. Fizy Health shows live per-vial cost on catalog and cart lines so staff quote on the number the clinic will actually pay.

  • Alternative

    How does Fizy Health change cash-pay economics?

    Fizy Health shows pass-through per-vial 503A cost before checkout with a disclosed facilitation fee, $0/mo plus pass-through pricing and 9% facilitation, one validated batch cart for refill day, and rejection prevention before payment.

Sources reviewed June 2026

  • RxFul public website (rxful.com), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

See cash-pay margin before you order.

See how Fizy Health shows landed cost before you quote, batches refill day in one cart, and validates orders before you pay. Free to start.

Fizy Health vs RxFulStart Ordering Free